Sehr P - Search Results

1

Suppression of non-specific binding in serological Luminex assays.

Waterboer T, Sehr P, Pawlita M. Waterboer T, et al. Among authors: sehr p. J Immunol Methods. 2006 Feb 20;309(1-2):200-4. doi: 10.1016/j.jim.2005.11.008. Epub 2005 Dec 19. J Immunol Methods. 2006. PMID: 16406059

2

Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.

Brown D, Müller M, Sehr P, Pawlita M, Seitz H, Rubio I, Antonello J, Radley D, Roberts C, Saah A. Brown D, et al. Among authors: sehr p. Vaccine. 2014 Oct 7;32(44):5880-7. doi: 10.1016/j.vaccine.2014.08.004. Epub 2014 Aug 19. Vaccine. 2014. PMID: 25148777

3

High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.

Sehr P, Rubio I, Seitz H, Putzker K, Ribeiro-Müller L, Pawlita M, Müller M. Sehr P, et al. PLoS One. 2013 Oct 4;8(10):e75677. doi: 10.1371/journal.pone.0075677. eCollection 2013. PLoS One. 2013. PMID: 24124504 Free PMC article.

4

Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in India.

Bhatla N, Nene BM, Joshi S, Esmy PO, Poli URR, Joshi G, Verma Y, Zomawia E, Pimple S, Prabhu PR, Basu P, Muwonge R, Hingmire S, Sauvaget C, Lucas E, Pawlita M, Gheit T, Jayant K, Malvi SG, Siddiqi M, Michel A, Butt J, Sankaran S, Kannan TPRA, Varghese R, Divate U, Willhauck-Fleckenstein M, Waterboer T, Müller M, Sehr P, Kriplani A, Mishra G, Jadhav R, Thorat R, Tommasino M, Pillai MR, Sankaranarayanan R; Indian HPV vaccine study group. Bhatla N, et al. Among authors: sehr p. Papillomavirus Res. 2018 Jun;5:163-171. doi: 10.1016/j.pvr.2018.03.008. Epub 2018 Mar 22. Papillomavirus Res. 2018. PMID: 29578097 Free PMC article. Clinical Trial.

5

Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study.

Sankaranarayanan R, Joshi S, Muwonge R, Esmy PO, Basu P, Prabhu P, Bhatla N, Nene BM, Shaw J, Poli URR, Verma Y, Zomawia E, Pimple S, Tommasino M, Pawlita M, Gheit T, Waterboer T, Sehr P, Pillai MR; Indian HPV vaccine study group. Sankaranarayanan R, et al. Among authors: sehr p. Vaccine. 2018 Aug 6;36(32 Pt A):4783-4791. doi: 10.1016/j.vaccine.2018.02.087. Epub 2018 Mar 15. Vaccine. 2018. PMID: 29551226 Clinical Trial.

6

Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.

Sankaranarayanan R, Prabhu PR, Pawlita M, Gheit T, Bhatla N, Muwonge R, Nene BM, Esmy PO, Joshi S, Poli UR, Jivarajani P, Verma Y, Zomawia E, Siddiqi M, Shastri SS, Jayant K, Malvi SG, Lucas E, Michel A, Butt J, Vijayamma JM, Sankaran S, Kannan TP, Varghese R, Divate U, Thomas S, Joshi G, Willhauck-Fleckenstein M, Waterboer T, Müller M, Sehr P, Hingmire S, Kriplani A, Mishra G, Pimple S, Jadhav R, Sauvaget C, Tommasino M, Pillai MR; Indian HPV Vaccine Study Group. Sankaranarayanan R, et al. Among authors: sehr p. Lancet Oncol. 2016 Jan;17(1):67-77. doi: 10.1016/S1470-2045(15)00414-3. Epub 2015 Dec 2. Lancet Oncol. 2016. PMID: 26652797 Free PMC article. Clinical Trial.

7

The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies.

Rubio I, Seitz H, Canali E, Sehr P, Bolchi A, Tommasino M, Ottonello S, Müller M. Rubio I, et al. Among authors: sehr p. Virology. 2011 Jan 20;409(2):348-59. doi: 10.1016/j.virol.2010.10.017. Epub 2010 Nov 11. Virology. 2011. PMID: 21074234

8

Antibodies against Gag are diagnostic markers for feline foamy virus infections while Env and Bet reactivity is undetectable in a substantial fraction of infected cats.

Romen F, Pawlita M, Sehr P, Bachmann S, Schröder J, Lutz H, Löchelt M. Romen F, et al. Among authors: sehr p. Virology. 2006 Feb 20;345(2):502-8. doi: 10.1016/j.virol.2005.10.022. Epub 2005 Nov 16. Virology. 2006. PMID: 16297422

9

Seroprevalence of 34 human papillomavirus types in the German general population.

Michael KM, Waterboer T, Sehr P, Rother A, Reidel U, Boeing H, Bravo IG, Schlehofer J, Gärtner BC, Pawlita M. Michael KM, et al. Among authors: sehr p. PLoS Pathog. 2008 Jun 20;4(6):e1000091. doi: 10.1371/journal.ppat.1000091. PLoS Pathog. 2008. PMID: 18566657 Free PMC article.

10

Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia.

Waterboer T, Neale R, Michael KM, Sehr P, de Koning MNC, Weißenborn SJ, Sampogna F, Abeni D, Green AC, Bouwes Bavinck JN, Pawlita M, The Epi-Hpv-Uv-Ca Group. Waterboer T, et al. Among authors: sehr p. J Gen Virol. 2009 Aug;90(Pt 8):1986-1998. doi: 10.1099/vir.0.010637-0. Epub 2009 Apr 22. J Gen Virol. 2009. PMID: 19386782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results